Indaptus Therapeutics, Inc.

INDP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 5 employees
116
SEC Filings
$1.16
Close 2026-09-03
5
Employees

Business Summary

Indaptus Therapeutics is a clinical-stage biotechnology company developing systemically-administered anti-cancer and anti-viral immunotherapies. Its patented technology uses attenuated and killed, non-pathogenic, Gram-negative bacteria designed for reduced intravenous toxicity while activating innate and adaptive immunity. Its lead candidate, Decoy20, was evaluated in a Phase 1 trial for advanced solid tumors, including in combination with BeiGene's anti-PD-1 antibody Tislelizumab. The company has discontinued clinical enrollment and is evaluating strategic options including potential acquisition of a target company.

Latest Stock Quote

INDP 2026-09-03 $1.16 O:$1.16 H:$1.19 L:$1.14 Vol:0.2M VWAP:$1.1561
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001493152-26-010585EDGAR84K words
2025-03-132024-12-310001493152-25-010136EDGAR76K words
2024-03-132023-12-310001493152-24-009769EDGAR60K words
2023-03-172022-12-310001493152-23-008010EDGAR61K words
2022-03-212021-12-310001493152-22-007319EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001493152-26-037579EDGAR17K words
2025-11-122025-09-300001493152-25-021759EDGAR18K words
2025-08-132025-06-300001641172-25-023333EDGAR17K words
2025-05-142025-03-310001641172-25-010099EDGAR14K words
2024-11-122024-09-300001493152-24-044537EDGAR42K words
2024-08-122024-06-300001493152-24-031158EDGAR41K words
2024-05-082024-03-310001493152-24-018162EDGAR39K words
2023-11-062023-09-300001493152-23-039523EDGAR41K words
2023-08-142023-06-300001493152-23-028059EDGAR41K words
2023-05-112023-03-310001493152-23-016268EDGAR39K words
2022-11-102022-09-300001493152-22-031392EDGAR—
2022-08-082022-06-300001493152-22-021562EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-100001493152-26-042037EDGAR13K words
2026-09-040001493152-26-041532EDGAR1K words
2026-09-010001493152-26-040926EDGAR23K words
2026-08-130001493152-26-037574EDGAR3K words
2026-04-030001493152-26-015079EDGAR1K words
2026-03-240001493152-26-012372EDGAR2K words
2026-02-270001493152-26-008326EDGAR2K words
2026-02-120001493152-26-006330EDGAR4K words
2026-01-200001493152-26-002850EDGAR1K words
2026-01-080001493152-26-001004EDGAR1K words

116 total filings indexed. 89 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology anti-viral-immunotherapy advanced-solid-tumors

Company Identity

CIK0001857044
TickerINDP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.indaptusrx.com
Listed2021-08-04

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 1c68a5877370f7b07e4ca245dede4a229cfa4fbe78421aa82f1c81bbb19b26a3
parent: a505e48cc9f2f899e2e62fd18f04de86a43d884e3b4e730e5e2e9844b8f611fe
content hash: 277dbde5ac897ccec565b5ee6eb6349def451fe8c6b8ac8ad28a6762c60ce6fa
signed: 2026-09-29T12:01:51.331Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up INDP using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on INDP, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/INDP (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.